150 related articles for article (PubMed ID: 10526762)
1. On calculating treatment satisfaction.
Bradley C
Diabetes Care; 1999 Oct; 22(10):1760. PubMed ID: 10526762
[No Abstract] [Full Text] [Related]
2. Insulin lispro (Humalog), a novel fast-acting insulin analogue: guidelines for its practical use.
Nobels FR; Hermans MP; De Leeuw I
Acta Clin Belg; 1999 Oct; 54(5):246-54. PubMed ID: 10555382
[No Abstract] [Full Text] [Related]
3. Mixing insulin lispro and ultralente insulin.
Bastyr EJ; Holcombe JH; Anderson JH; Clore JN
Diabetes Care; 1997 Jun; 20(6):1047-8. PubMed ID: 9167130
[No Abstract] [Full Text] [Related]
4. Premixed formulations of insulin lispro. Activity profiles in type 1 diabetic patients.
Rave K; Heinemann L; Puhl L; Gudat U; Woodworth JR; Weyer C; Heise T
Diabetes Care; 1999 May; 22(5):865-6. PubMed ID: 10332707
[No Abstract] [Full Text] [Related]
5. Impact on clinical status and quality of life of switching from regular insulin to insulin lispro among patients using insulin pumps.
Campbell RK; Sclar DA; Robison LM; Stowers JK; Ferguson JC; Trippe BS; Kayne DM
Diabetes Educ; 1998; 24(1):95-9. PubMed ID: 9526330
[No Abstract] [Full Text] [Related]
6. Updating the insulin lispro file.
Grossman LD
CMAJ; 1998 May; 158(9):1132-3. PubMed ID: 9597962
[No Abstract] [Full Text] [Related]
7. [How should we use the short-acting insulin analog Lys-Pro in external continuous subcutaneous pumps?].
Guerci B; Jeandidier N; Lassmann-Vague V; Renard E; Hanaire-Broutin H
Diabetes Metab; 2000 Dec; 26(6):513-9. PubMed ID: 11173725
[TBL] [Abstract][Full Text] [Related]
8. Comparison of human regular and lispro insulins after interruption of continuous subcutaneous insulin infusion and in the treatment of acutely decompensated IDDM.
Attia N; Jones TW; Holcombe J; Tamborlane WV
Diabetes Care; 1998 May; 21(5):817-21. PubMed ID: 9589247
[TBL] [Abstract][Full Text] [Related]
9. Alternative insulin delivery systems: how demanding should the patient be?
Polonsky KS; Byrne MM; Sturis J
Diabetologia; 1997 Jul; 40 Suppl 2():S97-101. PubMed ID: 9248709
[No Abstract] [Full Text] [Related]
10. Health-related quality-of-life results from multinational clinical trials of insulin lispro. Assessing benefits of a new diabetes therapy.
Kotsanos JG; Vignati L; Huster W; Andrejasich C; Boggs MB; Jacobson AM; Marrero D; Mathias SD; Patrick D; Zalani S; Anderson J
Diabetes Care; 1997 Jun; 20(6):948-58. PubMed ID: 9167105
[TBL] [Abstract][Full Text] [Related]
11. [Patients' experiences with insulin lispro in daily use. Yesterday's innovation--today's standard therapy].
Bergis KH
Krankenpfl J; 1999 Sep; 37(9):347-9. PubMed ID: 10542572
[No Abstract] [Full Text] [Related]
12. Lipoatrophy associated with lispro insulin in insulin pump therapy: an old complication, a new cause?
Griffin ME; Feder A; Tamborlane WV
Diabetes Care; 2001 Jan; 24(1):174. PubMed ID: 11194227
[No Abstract] [Full Text] [Related]
13. Glucose profiles in a type 1 diabetic patient successively treated with CSII using regular insulin, lispro and an implantable insulin pump.
Catargi B; Breilh D; Roger P; Tabarin A
Diabetes Metab; 2000 May; 26(3):210-4. PubMed ID: 10880895
[TBL] [Abstract][Full Text] [Related]
14. Insulin Pumps.
Pickup JC
Diabetes Technol Ther; 2018 Feb; 20(S1):S30-S40. PubMed ID: 29437475
[No Abstract] [Full Text] [Related]
15. [Insulin doses adaptation with insulin Lys-pro in external pump].
Grimaldi A; Sachon C; Timsit J
Diabetes Metab; 2001 Jun; 27(3):386-7. PubMed ID: 11431606
[No Abstract] [Full Text] [Related]
16. Insulin aspart: a review of its use in the management of type 1 and 2 diabetes mellitus.
Chapman TM; Noble S; Goa KL
Drugs; 2002; 62(13):1945-81. PubMed ID: 12215068
[TBL] [Abstract][Full Text] [Related]
17. The use of lispro for high sugar content snacks between meals in intensive insulin regimens.
Kong N; Kitchen MM; Ryder RE
Diabet Med; 2000 Apr; 17(4):331-2. PubMed ID: 10821304
[No Abstract] [Full Text] [Related]
18. In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine.
Bruttomesso D; Crazzolara D; Maran A; Costa S; Dal Pos M; Girelli A; Lepore G; Aragona M; Iori E; Valentini U; Del Prato S; Tiengo A; Buhr A; Trevisan R; Baritussio A
Diabet Med; 2008 Mar; 25(3):326-32. PubMed ID: 18307459
[TBL] [Abstract][Full Text] [Related]
19. Cannula occlusion with use of insulin lispro and insulin infusion system.
Wright AW; Little JA
Diabetes Care; 1998 May; 21(5):874-5. PubMed ID: 9589263
[No Abstract] [Full Text] [Related]
20. Closing the Loop.
Nimri R; Audon P; Pinsker JE; Dassau E
Diabetes Technol Ther; 2018 Feb; 20(S1):S41-S54. PubMed ID: 29437478
[No Abstract] [Full Text] [Related]
[Next] [New Search]
